What's new
-
-
New PGDs - see
PGDs section
-
-
-
Formulary Group Decisions
May 2010
- Febuxostat tablets (Adenuric®)
- Fondaparinux sodium, 2.5mg/0.5mL solution for injection, pre-filled syringe (Arixtra®)
- Histrelin acetate, 50mg subcutaneous implant (Vantas®)
- Lenalidomide capsules (Revlimid®)
- Raltegravir tablet (Isentress®)
- Tobramycin 300mg/4mL nebuliser solution (Bramitob®)
- Ustekinumab injection (Stelara®)